New SureSeq CLL + CNV V3 panel improves understanding of CLL OGT has announced the launch of its enhanced SureSeq CLL + CNV ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Cytomos has announced that it has raised $5m in an oversubscribed funding round to scale up production of its cell analysis ...

A precise and realistic TPP can define a clear path to market and commercial success by bridging the gap between research and ...

Curve Therapeutics has appointed Rab Prinjha as Chief Research and Development (R&D) Officer. Rab is a proven R&D leader with ...

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

Commit Biologics has announced the appointment of Mikkel Wandahl Pedersen as Chief Scientific Officer (CSO). Mikkel is a ...

Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer.

There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...